Focus

BioNTech

LATEST

FDA Fails to Address DNA Adulteration Concerns

FDA Fails to Address DNA Adulteration Concerns
|

COVID Vaccine Maker Cuts Revenue Projections Due to Drop in Demand

COVID Vaccine Maker Cuts Revenue Projections Due to Drop in Demand
|